MedTrace Logo

Lean Body Mass in Head and Neck Cancer Patients During Cisplatin-based Chemoradiation

NCT05890859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-06-06

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the changes in body composition in head and neck cancer patients during treatment. The main questions it aims to answer are: What is the rate of lean body mass loss and how is it associated with changes in muscle strength and functional performance? Is the lean body mass loss impacted by adding chemotherapy to the radiation treatment? Participants will be asked to undergo five body composition scans during treatment and undergo tests for muscle strength and functional performance before and after treatment.

Conditions

  • Head and Neck Cancer Patients
  • Lean Body Mass
  • Body Composition Changes

Interventions

DIAGNOSTIC_TEST

DXA scan

The patients will undergo 5 DXA scans fro pre- to post treatment

BEHAVIORAL

Physical testing

The patients will undergo tests for maximal muscle strength and functional performance before and after treatment

Sponsors & Collaborators

  • Department of Public Health, Denmark

    lead OTHER

Principal Investigators

  • Simon Lønbro, PhD · University of Aarhus

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-05
Primary Completion
2017-07-31
Completion
2023-05-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05890859 on ClinicalTrials.gov